UBS Sweeps Targets; FIS Takes a Hit From William Blair

William Blair cut FIS from Buy to Hold on Thursday, the sharpest rating change of the day for the fintech giant. The firm issued no revised price target. FIS carries a market cap of $20.1 billion. Short interest sits at just 3.8% of free float, so bears are not piling in yet.

UBS ran a wide sweep of target price revisions across multiple sectors. The bank's most dramatic cut fell on EME. UBS trimmed its target on EMCOR Group to $925 from $1,065, a $140 reduction, while keeping its Buy rating intact. EMCOR has a $31 billion market cap. The cut stands out given the stock commands analyst consensus that skews strongly bullish.

On the more positive side, UBS lifted its target on ECHO to $160 from $150. EchoStar carries significant short interest at 17.4% of free float. A $16.3 billion market cap stock with that level of short interest and a fresh Buy-rated target hike makes it one of the more interesting setups from today's action.

AMGN received a target bump to $440 from $384 at Canaccord Genuity, though the Hold rating remained unchanged. Medicare Advantage enrolment hit a record 36.2 million beneficiaries in July 2026, crossing 51% penetration, a backdrop that may support biotech sentiment broadly.

KDP and DD also received UBS target increases, both retaining Buy ratings.